Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel in Treating Patients With Relapsed Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Customized Adjuvant Chemotherapy (GECP-SCAT)
- Status
- COMPLETED
- Phase
- PHASE3
Iressa as Second Line Therapy in Advanced NSCLC-Asia
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I Study of Intraperitoneal Hyperthermic Docetaxel
- Status
- COMPLETED
- Phase
- PHASE1
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer.
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer.
- Status
- COMPLETED
- Phase
- PHASE2